A major issue in transplantation immunology is the nature ofthe cellular interactions and responses involved in in vivo responses to tissue allografts . In previous work, we demonstrated that skin allograft rejection is initiated and mediated only by T cell populations that contained both lymphokine-secreting T helper (Th)t cells and cytolytic T effector (Teff) cells reactive against the alloantigens of the graft (1). We further showed that skin allograft rejection could result from interactions between Th cells and Tefr cells of different Lyt phenotypes and of different antigen specificities (1). The present study specifically addresses the cellular pathways and interactions involved in the rejection of MHC class I disparate grafts . Though rejection of MHC class I disparate skin grafts can result from an interaction between L3T4+ class II-specific Th cells and Lyt-2+ class I-specific Test cells, rejection of MHC class I disparate grafts can also be mediated by isolated Lyt-2+ T cell populations (1-3). However, uncertain in this latter mechanism is whether the Th and Teff cellular functions, contained within the isolated Lyt-2`T cell population and requisite to reject class I disparate skin allografts, are mediated by functionally distinct populations of Th and Teff cells or by single populations of dual-function Th/Tef cells (4-6). To address these two possibilities, we tested whether class I-specific Th cells provided help in vivo for the activation of physically distinct populations of Teff cells capable of rejecting skin allografts .
A major issue in transplantation immunology is the nature ofthe cellular interactions and responses involved in in vivo responses to tissue allografts . In previous work, we demonstrated that skin allograft rejection is initiated and mediated only by T cell populations that contained both lymphokine-secreting T helper (Th)t cells and cytolytic T effector (Teff) cells reactive against the alloantigens of the graft (1) . We further showed that skin allograft rejection could result from interactions between Th cells and Tefr cells of different Lyt phenotypes and of different antigen specificities (1) . The present study specifically addresses the cellular pathways and interactions involved in the rejection of MHC class I disparate grafts . Though rejection of MHC class I disparate skin grafts can result from an interaction between L3T4+ class II-specific Th cells and Lyt-2+ class I-specific Test cells, rejection of MHC class I disparate grafts can also be mediated by isolated Lyt-2+ T cell populations (1) (2) (3) . However, uncertain in this latter mechanism is whether the Th and Teff cellular functions, contained within the isolated Lyt-2`T cell population and requisite to reject class I disparate skin allografts, are mediated by functionally distinct populations of Th and Teff cells or by single populations of dual-function Th/Tef cells (4) (5) (6) . To address these two possibilities, we tested whether class I-specific Th cells provided help in vivo for the activation of physically distinct populations of Teff cells capable of rejecting skin allografts .
In the present study, we show that class I-reactive T cells reject skin allografts for which they are specific, but, unlike class II-reactive T cells, fail to generate help for the rejection of third-party skin allografts . Nevertheless, Class I-allospecific Th cells do recognize and respond to class I allodeterminants expressed on skin grafts, but the responding T cells consume nearly all of the lymphokine produced. These findings are most consistent with the participation in anti-class I rejection responses of dual-function Th/Teff cells that consume the helper lymphokines that they secrete.
Mice. B10 nu/nu female mice were obtained from the Small Animal Section, National Institutes of Health, Bethesda, MD. C57BL/6 (B6) and C57BL/10 (B10) mice were obtained from The Jackson Laboratory, Bar Harbor, ME . B6 .Tlaa breeder mice were a generous gift of Dr. L . Flaherty, Albany, NY (7) . B10 .QBR, B6 .C-H-2 6m' (bml) (8), B6 .C-H-26`"' 2 (bm12) (9), B6 .C-H-2 6'"6 (bm6) (10) , and Fi mice were bred in our own animal facility.
mAbs. Anti-L3T4 mAb was either a culture supernatant of the hybridoma cell line GK1 .5 (11) or was an ascites of the hybridoma cell line RL-172/4 (12) . Anti-I-A 6 mAb was a culture supernatant of the hybridoma cell line M5/114 (13) . Rat anti-murine IL-2-R mAb was a mouse ascites of the hybridoma cell line 7134 (14) .
Cell Fractionation. Depletion of L3T4' T cells was accomplished by incubating spleen cells at a density of 10' cells/ml with anti-L3T4 (1 :2 dilution of GK1 .5 or a 1 :100 dilution of RL-172/4) mAb for 30 min at 4°C . Cells were then pelleted, resuspended, and incubated with complement for 50 min at 37'C . The cells treated with GK1 .5 were resuspended at 10 7/ml in low toxicity rabbit complement (Cedar Lane, Ontario, Canada) diluted 1 :10 . The cells treated with RL-172/4 were resuspended at 10 8/ml in Guinea pig complement (Gibco Laboratories, Chagrin Falls, OH) diluted 1 :3 . Treated cells were washed three times before injection into experimental animals or placement in culture as indicated .
Skin Grafting ofNormal B6Mice and B10 nu/nu Mice. Mice were engrafted on the left thorax with two tailskin grafts, separated by a host skin bridge, according to an adaptation of the method of Billingham and Medawar (15) . Bandages were removed on day 7, and the grafts were scored daily until rejection or the end point of the experiment .
Adoptive Transfer. Female B10 nude mice were engrafted as above. On day 1, the mice were injected intravenously with 5 x 10 7 spleen cells from unprimed female B6 mice that had been untreated or treated with anti-L3T4 antibody and complement . Bandages were removed on day 7, and the grafts were scored daily until rejection or the end point of the experiment . This adoptive transfer model has been described in detail elsewhere (1).
Culture Conditions. Responder and stimulator populations were obtained either from primed or unprimed mice as indicated . Spleen stimulator cells were irradiated with 2,000 rad . Responder populations were depleted of adherent accessory cells by passage over Sephadex G-10 columns (16) . Responder spleen cells (4 x 10 5 ) and stimulator spleen cells (4 x 10 5 ) were cultured together for 4 d in 0.2 ml of culture medium at 37°C in 7 .5% C02, as previously described (16) , unless otherwise indicated . Where indicated, 0 .01 17o ascites of anti-IL-2-R mAb, 7134, was added to each culture to inhibit the consumption of IL-2 during the response period (17) . On day 4 of culture, 0 .1 ml of supernatant was obtained from each well and assayed by its ability to maintain the growth of an IL-2-dependent cell line, HT-2 (18) . Control experiments showed that the IL-2 content of the supernatants from these response cultures reached a plateau on day 4 . After 24 h, cultures of HT-2 cells were pulsed with luCi of We have previously demonstrated that most B6 mice must recruit Th cells with additional recognition specificities in order to initiate rejection responses against either Kbm6 or Qa-1 a disparate tailskin allografts (1, 3) . To assess the ability of MHC class I allodeterminants to function as in vivo helper de-terminants for the initiation of rejection responses against third-party bm6 or Qa1a skin allografts, we engrafted normal B6 mice with two skin grafts: an "indicator" graft on the lower part of the flank expressing only the target antigen; and an "inducer" graft on the upper part of the flank expressing both the target antigen and putative helper determinants . We then assessed the ability of the inducer graft to promote rejection of the indicator graft. In Table I , we examined the ability of inducer grafts expressing various helper determinants to initiate rejection of bm6 indicator grafts . It can be seen that inducer grafts expressing only target Kbm6 antigens failed to induce rejection of bm6 indicator grafts (group 1) . However, (bm6 x bml2)F1 inducer grafts expressing both target Kbm6 antigens and Ibm12 determinants, but not (B10 x bml2)Fl inducer grafts expressing Ibm12 determinants alone, initiated efficient rejection of indicator bm6 grafts (groups 2 and 3) . Thus, consistent with our previous observations (1), MHC class II Ibm12 allodeterminants were able to elicit T cell help necessary for the local activation of anti-K bms effector cells mediating the rejection of bm6 indicator skin allografts . More importantly, we also tested the ability of MHC class I (Kbm1) allodeterminants to function as in vivo "helper" determinants for this in vivo rejection response . We did so by using (bm6 x bml)Fl skin as the inducer graft so that it would express both Kbms target antigens as well as putative Kbml helper determinants . Expression of Kbm1 allodeterminants by the inducer graft provided a potent rejection stimulus as demonstrated by the rapid rejection of the inducer graft itself (group 4) . However, expression by the inducer graft of Kbm1 class I allodeterminants failed to initiate a significant rejection response against the bm6 indicator graft (group 4) . Similar results were obtained with (bm6 x bm10) inducer grafts expressing Kbm1o class I allodeterminants (data not shown) . Thus, unlike MHC class 11 alloantigens, MHC class I alloantigens failed to generate help for the initiation of third-party anti-K bm6 rejection responses.
In Table 11 , we reassessed the ability of Kbm1 class I allodeterminants to function as in vivo helper determinants using Qa-1 a disparate skin allografts from B6 .Tlaa mice as the indicator grafts . Inducer grafts expressing only Qa-1 a target antigens failed to induce rejection of Qa-la indicator grafts (group 1), whereas inducer grafts expressing both Qa-l a target antigens and Ibm12 helper determinants did induce rejection of Qa-1 a indicator grafts (group 2) . However, inducer grafts expressing both Qa-1 a target antigens and Kb-1 class I allodeterminants, despite being highly immunogenic as indicated by rejection of the inducer grafts themselves, failed to initiate rejection of the Qa-la indicator grafts (group 3) . Thus, MHC class I Kb-1 al_ lodeterminants also failed to generate help for the initiation of anti-Qa-la rejection responses.
Presence ofMHC Class IAllodeterminants Does not Suppress the Rejection ofIndicator Skin
Grafts Bearing Third-party K`Determinants. We think that K`allodeterminants expressed by skin grafts fail to induce the rejection of skin grafts expressing thirdparty Kbm6 or Qa-1 a determinants because they fail to elicit sufficient T cell help for the activation of Kbm6_ or Qa-la-specific Teff cells. However, an alternative possibility is that the response to Kb allodeterminants generates cells capable of down regulating the response to third-party alloantigens . To test this possibility, we assessed whether mice that had retained indicator bm6 skin grafts despite rejecting inducer (bm6 x bml)F1 grafts could subsequently reject these indicator grafts if provided with a proven source of T cell help. Therefore, we engrafted B6 mice with To test whether mice engrafted with (bm6 x bml)Fi inducer grafts were consequently rendered incapable of rejecting bm6 indicator grafts, we regrafted them on day 71 with a second inducer graft. Mice engrafted with (bm6 x bml2)Ft skin as a second inducer graft rejected their original bm6 indicator grafts with a MST of 12 d (Fig. 1 ). This rejection rate of bm6 indicator grafts was similar to that induced by (bm6 x bml2)Ft inducer grafts on naive mice (MST of 12 d). Thus, inducer skin grafts expressing MHC class I Kbmt allodeterminants as well as Kb m6 target determinants did not generate functionally detectable Kbm6-specific suppression. Failure ofLyt-2' T Cells to Generate Helpfor In Vivo Rejection of Third-party Allografts . We next considered the, possibility that L3T4' T cells present in normal engrafted mice might have interfered with the helper function of MHC class I-allospecific T cells . Consistent with such a possibility is the observation that mice reconstituted with isolated populations of Lyt-2' T cells frequently reject class I disparate skin allografts more rapidly than mice reconstituted with T cell populations containing both Lyt-2' and L3T4' T cells (3) . To examine the ability of MHC class I K" allodeterminants to function as in vivo helper determinants in the absence of L3T4' T cells, we adoptively transferred unfractionated or L3T4-spleen cells into B10 nude mice that had been engrafted with both inducer and indicator skin allografts (Table III) . We used the male H-Y antigen as the target antigen in this experiment because effector cells mediating the anti-HY rejection response are Lyt-2' and require additional help (1, 19) . Indeed, mice reconstituted with isolated Lyt-2' T cells failed to reject HY disparate B6 male indicator grafts . (Table III , group 1). More importantly, such mice failed to reject HY disparate indicator grafts even when engrafted with inducer grafts expressing both the HY target antigens and Kb"1t allodeterminants (Table III, bearing inducer grafts (Table III , group 2), confirming that mice reconstituted with isolated Lyt-2' T cells were capable of rejecting skin allografts bearing MHC class I allodeterminants (1-3). Thus, despite the absence of L3T4' T cells, Lyt-2' antiKbm1 T cells failed to provide help for the activation of anti-HY effector cells, even as they were rejecting the K`-bearing inducer grafts . Lyt-2' anti-HY effector cells were capable of rejecting the H-Y indicator grafts when help was provided by L3T4' Th cells, whether or not K" allodeterminants were present (Table III, . Lyt-2' Class I-specific Ti, Are Primed by Skin Grafts Expressing Allogeneic Class I Determinants. Because Kbm1 class I allodeterminants failed to activate Th cells able to induce the rejection of third-party skin allografts, it was necessary to ascertain that MHC class I-allospecific Th cells had in fact recognized and responded to Kbml class I allodeterminants expressed by bml inducer skin grafts . To assess the effect, if any, of bml skin allografts on anti-Kbm 1 lymphokine-secreting Lyt-2' Th cells, we compared the in vitro IL-2 secretion responses of Lyt-2' Th cells from naive mice and from mice that had been engrafted with, and had rejected, bml tailskin allografts . Anti-IL-2-R mAb was added to the in vitro response cultures to block consumption of IL-2 during the response period, thereby permitting an accurate and sensitive measure of the IL-2 produced (14, 17). As can be seen in Fig. 2 , Lyt-2' T cells from mice that had been engrafted with bml skin allografts exhibited a marked shift in their anti-Kbml dose/response curve in that they required -16-fold fewer stimulator cells for comparable IL-2 production than did Lyt-2' T cells from naive mice. In addition, the response of Lyt-2' T cells from burl-engrafted mice was greater at each stimulator cell dose than that of Lyt-2' T cells from naive mice . That these effects were specific for Kbmt allodeterminants expressed by the skin allograft is shown by the failure of Lyt-2' Th from bml-engrafted mice to manifest similarly increased responses to third-party class I H-2D9 allodeterminants (Fig. 2) . Thus, anti-Kbm 1 , Lyt-2' lymphokine-secreting Tb are specifically primed by Kbmt class I disparate skin allografts, demonstrating that Lyt-2' lymphokine-secreting Th cells do recognize and respond in vivo to class I allodeterminants expressed on skin.
Class I-specific T Cells Consume the IL-2 They Produce. Having determined that Lyt-2' lymphokine-secreting Th cells do respond to MHC class I allodeterminants ex- pressed on skin allografts, it was unclear why MHC class I-disparate inducer skin allografts did not activate Th cells able to induce rejection of third-party indicator skin grafts, as did MHC class 11-disparate inducer skin allografts . One possibility was that lymphokine-secreting Th cells specific for MHC class I or MHC class II alloantigens differed in the amount of lymphokines that they themselves consumed and so differed in the amount of helper lymphokines that they could provide to thirdparty Tern cells. To compare the amount of soluble IL-2 produced and consumed by T cells upon recognition of MHC class I and MHC class II allodeterminants, we measured IL-2 present in supernatants of response cultures under conditions in which consumption of IL-2 by responder cells either was permitted or was blocked by the presence of anti-IL-2-R mAb (14, 17) . It has been previously documented that anti-IL-2-R mAb fails to stimulate the secretion of IL-2 by populations of MHC class I-specific lymphokine-secreting Th cells (17) . It can be seen in Table IV that the activity of soluble IL-2 present in the supernatants of response cultures stimulated by recognition of Kbml class I allodeterminants was affected dramatically by the presence or absence of anti-IL-2-R mAb. Indeed, in the absence of anti-IL-2-R mAb, essentially all the IL-2 produced in response to recognition of Kbm1 class I allodeterminants was consumed, whereas that was not the case in response to Ibm12 class II allodeterminants (Table IV , exp. 1) . In a second experiment, we added anti-I-Ab mAb to the response cultures to block activation of Th cells recognizing Kbm1 class I allodeterminants in the context of I-Ab (17, 20) , so that we could focus exclusively on anti-Kbm 1 class I-restricted Th cells (Table IV, exp. 2) . It can be seen that either in the presence or absence of anti-I-A b mAb, anti-bml T cells consumed most of the IL-2 they produced (Table IV, exp. 2) . That the anti-I-Ab mAb was effective in these cultures is indicated by its blockade of the class II-restricted antiself response (Table IV, class II-allospecific T cells, K" class I-allospecific T cells consume essentially all the IL-2 produced .
Discussion
The present study demonstrates that, unlike recognition ofMHC class II allodeterminants, recognition ofMHC class I allodeterminants expressed on skin grafts fails to generate in vivo help for the rejection of third-party skin allografts . That MHC class I-allospecific Th cells recognize and respond to MHC class I allodeterminants expressed on skin grafts was shown by the fact that engraftment of mice with class I-disparate skin specifically primed lymphokine-secreting class I-allospecific Th cells . However, measurement of the IL-2 produced by class I-allospecific Th cells in response to MHC class I allodeterminants revealed that the responding cells consumed nearly all the IL-2 that was produced . Taken together, these data are most consistent with the concept that rejection of skin grafts expressing only class I allodeterminants is mediated by class I-allospecific dual-function Th/Tecc cells that secrete IL-2 when activated, but preferentially consume most ofthe helper lymphokines they secrete .
We have previously shown that the ability to reject skin allografts is not unique to a specialized subset of T cells of a given phenotype or a given function, since allograft rejection can result from interactions between distinct populations of lymphokine-secreting Th cells and lymphokine-responsive T,ff cells that are of different Lyt phenotypes (1) . Indeed, the interacting Th and T,ff cells can even express distinct antigen specificities, as is the case with Ibm12 -specific Th cells activating Kbm6 -specific T effector cells to reject Kbms -disparate skin grafts (1) . Thus, interaction with a distinct population of Th cells is one mechanism by which MHC class I-allospecific T,ff cells can be activated to reject skin allografts expressing MHC class I allodeterminants . However, these results did not address the possibility that a second rejection mechanism involving a single subpopulation of dual-function T cells that both secrete helper lymphokines and differentiate into cytolytic effector cells might also mediate graft rejection responses without any further cell-cell interaction requirements. T cell populations containing dual-function cells would be read out as containing both lymphokine-secreting Th cells and lymphokine-responsive Teff cells and so would be expected to reject skin allografts of appropriate specificities . Dual-function cells were especially likely to participate in rejection of class I-disparate skin allografts because: (a) rejection of class I-disparate skin allografts does not require interactions between phenotypically distinct T cell populations but can be mediated by a single population of Lyt-2' T cells; and (b) T cell clones with dual function have been shown to be capable of rejecting MHC class I-disparate pancreatic islet grafts (21) and Lyt-2+ class I-restricted dual-function cells have been shown capable of rejecting allogeneic tumor grafts (22) . However, it is not known whether T cells with dual-function capability actually play any role in in vivo allograft rejection responses of normal mice.
To distinguish between the possibilities that class I-disparate skin allografts activate distinct populations of helper lymphokine-secreting Th cells and lymphokineresponsive T,ff cells vs. activating a single population of dual-function T cells that produce their own helper lymphokines, we assessed the ability of T cells reactive against skin class I allodeterminants to provide help for the rejection ofthird-party skin allografts, in a manner analogous to that provided by MHC class II-allospecific Th cells. We specifically selected Kbm1 as the stimulatory MHC class I allodeterminant for these experiments, because the frequency of anti-Kbm 1 lymphokinesecreting Th cells is higher than for any other class I specificity we have examined (3, 23) , and because the quantity of helper lymphokine produced in anti-Kbm 1 responses is greater than for any other class I-allospecific response we have examined (23) . Even so, we observed a marked disparity in the relative abilities of anti-Kbm 1 vs . anti-Ibm12 T cells to provide help for Kbm6-or Qa-1a-specific Te1r cell populations. The failure of anti-Kbm 1 class I-allospecific T cells to provide help for third-party effector cell populations could have a basis in quantitative or qualitative factors.
It was conceivable that the precursor frequency of Kbml -specific Th cells, as opposed to that of Ibm 12 -specific Th cells, might be insufficient to provide help for thirdparty Tern cells. However, previous studies have documented that the frequencies of anti-K bm1 and anti-I b m12 lymphokine-secreting Th cell precursors are comparable (23, 24) .
It was conceivable that MHC class I-allospecific Th cells, while present in the engrafted host, did not respond to MHC class I allodeterminants expressed on skin cells. However, when we compared the responses of class I-allospecific IL-2-secreting Th cells from mice that had been engrafted with Kbm1 skin allografts with responses of cells from naive mice, we found that anti-Kb m1 lymphokine-secreting T cells were clearly primed by engraftment with bml skin . Thus, class I-allospecific Th cells do recognize and respond to MHC class I allodeterminants expressed on skin allografts .
Finally, it was conceivable that class I-allospecific Th cells might secrete very little lymphokine on a cell for cell basis, or alternatively, that class I-alloresponsive T cells might consume greater amounts of lymphokine than do class II-alloresponsive T cells. We addressed these points by stimulating anti-class I lymphokine responses in vitro and comparing the amount of soluble lymphokine secreted into the media when the consumption of these factors was either blocked or not. It was clear that the anti-class I lymphokine response was substantial when lymphokine consumption was blocked, but that when consumption was not blocked, the class I-reactive T cells consumed nearly all of the soluble lymphokine produced, leaving little soluble lymphokine in the medium . Thus, we think the failure of class I allodeterminants to provide help in vivo for activating third-party effector cells is due to the fact that lymphokine-secreting T cells reactive to class I allodeterminants on skin grafts consume most of the helper lymphokines they produce. This property is precisely that expected of dual-function Th/T ef cells and so indicates that rejection of skin allografts expressing only class I disparities can be mediated by dual-function T cells that preferentially consume the helper factors they secrete. This conclusion is entirely consistent with previous work demonstrating that only T cell populations containing both Th and Terr cellular functions are able to mediate graft rejection (1). Thus, Th and Tern cellular functions may be generated by distinct, interacting cellular populations, or may be generated by a single population of dual-function cells.
The observation that MHC class I allodeterminants fail to trigger T cell help for the in vivo activation of Tern cells with third-party specificities sharply contrasts with their ability to do so in vitro (25) . Dual-function T cells appear similar to conventional Th cells in that they secrete soluble helper lymphokines. Dual-function T cells are also similar to conventional Terr cells in that they bind soluble lymphokine to specific receptors on the cell surface, and this binding is susceptible to blockade by anti-receptor antibody. Thus, the primary advantage that dual-function T cells have over conventional helper-dependent Teff cells is that the dual-function cell is necessarily more proximal to the secreted lymphokines. We think that the proximity advantage is largely negated in vitro where T cell subpopulations are artificially brought together. In contrast, proximity advantages are likely to be of critical importance in vivo, where T cells have to migrate to the reaction site, particularly when secreted helper lymphokine is present in limiting amounts.
Taken together, these data demonstrate that there are two Tern cell populations able to mediate the rejection of MHC class I-disparate skin grafts . There are class I-specific effector cells, such as anti-Kbm s effector cells, that are themselves unable to secrete lymphokine but can use exogenous T cell help to become activated and reject bm6 skin allografts . In addition, there are class I-specific effector cells, such as anti-Kb-1 effector cells, that produce and consume their own Th factors in response to skin grafts expressing Kbm1 allodeterminants . Thus, MHC class I-disparate grafts can be rejected by two cellular mechanisms depending on the ability of the Teen cell population to secrete lymphokine in response to class I alloantigen : (a) a dual-function cell mechanism and (b) a mechanism requiring an interaction between distinct populations of lymphokine-secreting Th cells and lymphokineresponsive Teen cells.
Summary
The present study further characterizes the cellular mechanisms involved in the in vivo rejection of MHC class I-disparate skin allografts . Previously, we demonstrated that class I-specific rejection responses could result from collaborations between distinct populations of lymphokine-secreting T helper (Th) and lymphokineresponsive T effector (Teff) cells. In the present study, we have assessed the possibility that class I-specific rejection responses could also result from a second cellular mechanism involving a single population of dual-function Th/Teff cells that would not have any further requirement for cell-cell collaboration. Our experimental strategy was to determine the ability of MHC class I-allospecific T cells, in response to class I allodeterminants expressed on skin grafts, to provide help in vivo for activation of helper-dependent Teff cells. We found that class I anti-K bme _allospecific T cells would reject bml skin allografts, but would not generate help for the activation of helper-dependent effector cells that were specific for third-party skin allografts (e .g., grafts expressing Kbms, Qala, or HY allodeterminants). This failure of anti-Kbm' T cells to provide help in response to bml skin allografts was not due to an inability of lymphokine-secreting anti-Kbm' Th cells to recognize and respond in vivo to Kbm1 allodeterminants expressed on skin, since lymphokine-secreting anti-Kb,' T h cells were specifically primed in animals engrafted with bml skin allografts . Nor was any evidence found that this failure was due to active suppression of anti-Kbm' helper activity. Rather, we found that anti-Kbm' T cells consumed nearly all of the helper factors they secreted . Taken together, these results are most consistent with the in vivo activity of dual-function Th/Teff cells that consume the lymphokines they secrete.
Thus, this study demonstrates that MHC class I-disparate skin allografts can be rejected by two mechanisms, depending on the ability of the allospecific Tefr cell to secrete helper lymphokines . MHC class I-disparate grafts can be rejected by (a)
class I-allospecific Tern cells that are unable to produce lymphokine but are responsive to exogenous T cell help ; and (b) class I-allospecific dual-function Th/Te rr cells that are able to both produce and consume soluble lymphokine .
